Author Contributions: Dr Reddy had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
Study concept and design: Reddy, Gill, Rochon.
Acquisition of data: Reddy, Kalkar, Wu.
Analysis and interpretation of data: Reddy, Gill, Kalkar, Wu, Anderson, Rochon.
Drafting of the manuscript: Reddy.
Critical revision of the manuscript for important intellectual content: Gill, Kalkar, Wu, Anderson, Rochon.
Statistical analysis: Kalkar, Wu.
Obtained funding: Rochon.
Administrative, technical, or material support: Kalkar, Wu, Anderson.
Study supervision: Rochon.
Financial Disclosures: Dr Reddy reports receiving honoraria or consulting fees from Smith and Nephew, Molynlycke, and Merck. No other authors reported financial disclosures.
Funding/Support: This work was supported by a Canadian Institutes of Health Research Interdisciplinary Capacity Enhancement grant H0A-80075. Dr Gill was supported by an Ontario Ministry of Health and Long-Term Care Career Scientist Award.
Role of the Sponsors: The funding organizations did not participate in the design or conduct of the study, in the collection, analysis, or interpretation of the data, or in the preparation, review, or approval of the manuscript.
Additional Contributions: Peter Hotez, MD, PhD, Department of Microbiology, Immunology, and Tropical Medicine, George Washington University, and Nilanthi de Silva, MBBS, MSc (Lond), MD, University of Kelaniya, Sri Lanka, provided their insightful comments and review of the manuscript. Dr Hotez is co-chair of the Scientific Advisory Council of the Sabin Vaccine Institute, Connecticut, and a member of the Academic Advisory Board for the Pfizer Fellowships in Infectious Diseases. Dr de Silva is a member of the Mebendazole Advisory Committee, an independent body of experts that advises Johnson & Johnson and the Mebendazole Donation Initiative. Neither received any compensation for their contributions.